BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 26992378)

  • 1. Adhesion molecules and the extracellular matrix as drug targets for glioma.
    Shimizu T; Kurozumi K; Ishida J; Ichikawa T; Date I
    Brain Tumor Pathol; 2016 Apr; 33(2):97-106. PubMed ID: 26992378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiogenesis and invasion in glioma.
    Onishi M; Ichikawa T; Kurozumi K; Date I
    Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of cellular adhesion and invasion in gliomas].
    Sasaki H; Yoshida K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
    [No Abstract]   [Full Text] [Related]  

  • 4. Mechanisms of tumor development and anti-angiogenic therapy in glioblastoma multiforme.
    Onishi M; Kurozumi K; Ichikawa T; Date I
    Neurol Med Chir (Tokyo); 2013; 53(11):755-63. PubMed ID: 24162241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis and invasion in gliomas.
    Bello L; Giussani C; Carrabba G; Pluderi M; Costa F; Bikfalvi A
    Cancer Treat Res; 2004; 117():263-84. PubMed ID: 15015565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion.
    Bellail AC; Hunter SB; Brat DJ; Tan C; Van Meir EG
    Int J Biochem Cell Biol; 2004 Jun; 36(6):1046-69. PubMed ID: 15094120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ECM-mediated glioma cell invasion.
    Goldbrunner RH; Bernstein JJ; Tonn JC
    Microsc Res Tech; 1998 Nov; 43(3):250-7. PubMed ID: 9840803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiogenesis and invasion in malignant gliomas.
    Chi A; Norden AD; Wen PY
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Annexin A2 regulates angiogenesis and invasion phenotypes of malignant glioma.
    Onishi M; Ichikawa T; Kurozumi K; Inoue S; Maruo T; Otani Y; Fujii K; Ishida J; Shimazu Y; Yoshida K; Michiue H; Antonio Chiocca E; Date I
    Brain Tumor Pathol; 2015 Jul; 32(3):184-94. PubMed ID: 25697644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour angiogenesis: its mechanism and therapeutic implications in malignant gliomas.
    Wong ML; Prawira A; Kaye AH; Hovens CM
    J Clin Neurosci; 2009 Sep; 16(9):1119-30. PubMed ID: 19556134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biology of angiogenesis and invasion in glioma.
    Tate MC; Aghi MK
    Neurotherapeutics; 2009 Jul; 6(3):447-57. PubMed ID: 19560735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cilengitide treatment for malignant glioma: current status and future direction.
    Kurozumi K; Ichikawa T; Onishi M; Fujii K; Date I
    Neurol Med Chir (Tokyo); 2012; 52(8):539-47. PubMed ID: 22976135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy for recurrent malignant glioma in adults.
    Mrugala MM; Kesari S; Ramakrishna N; Wen PY
    Expert Rev Anticancer Ther; 2004 Oct; 4(5):759-82. PubMed ID: 15485312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of glioma-associated neovascularization.
    Hardee ME; Zagzag D
    Am J Pathol; 2012 Oct; 181(4):1126-41. PubMed ID: 22858156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biomarker-guided anti-angiogenic targeted therapy for malignant glioma.
    Yan C; Wang J; Yang Y; Ma W; Chen X
    J Cell Mol Med; 2019 Aug; 23(8):4876-4882. PubMed ID: 31210419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glioma infiltration and extracellular matrix: key players and modulators.
    Ferrer VP; Moura Neto V; Mentlein R
    Glia; 2018 Aug; 66(8):1542-1565. PubMed ID: 29464861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Angiogenesis inhibition in neurooncology. A very promising therapy strategy for malignant glioma].
    Tabatabai G; Stupp R
    Nervenarzt; 2010 Aug; 81(8):936-9. PubMed ID: 20669004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periostin (POSTN) Regulates Tumor Resistance to Antiangiogenic Therapy in Glioma Models.
    Park SY; Piao Y; Jeong KJ; Dong J; de Groot JF
    Mol Cancer Ther; 2016 Sep; 15(9):2187-97. PubMed ID: 27307601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the extracellular matrix in angiogenesis in malignant glioma tumors.
    Wang D; Anderson JC; Gladson CL
    Brain Pathol; 2005 Oct; 15(4):318-26. PubMed ID: 16389944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.